428 related articles for article (PubMed ID: 22550000)
21. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/β-catenin signaling pathway in a DKK1-dependent manner.
Zhao X; Sun S; Xu J; Luo Y; Xin Y; Wang Y
Oncol Rep; 2018 Aug; 40(2):767-774. PubMed ID: 29845282
[TBL] [Abstract][Full Text] [Related]
23. Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.
Kim JT; Li J; Jang ER; Gulhati P; Rychahou PG; Napier DL; Wang C; Weiss HL; Lee EY; Anthony L; Townsend CM; Liu C; Evers BM
Carcinogenesis; 2013 May; 34(5):953-61. PubMed ID: 23354304
[TBL] [Abstract][Full Text] [Related]
24. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
Hu T; Fei Z; Su H; Xie R; Chen L
Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
[TBL] [Abstract][Full Text] [Related]
25. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
[TBL] [Abstract][Full Text] [Related]
26. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.
Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602
[TBL] [Abstract][Full Text] [Related]
27. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signaling.
Martins-Neves SR; Paiva-Oliveira DI; Wijers-Koster PM; Abrunhosa AJ; Fontes-Ribeiro C; Bovée JV; Cleton-Jansen AM; Gomes CM
Cancer Lett; 2016 Jan; 370(2):286-95. PubMed ID: 26577806
[TBL] [Abstract][Full Text] [Related]
29. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
30. SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells.
Zhang F; Chen A; Chen J; Yu T; Guo F
Asian Pac J Cancer Prev; 2011; 12(1):239-45. PubMed ID: 21517265
[TBL] [Abstract][Full Text] [Related]
31. β-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer.
Lee H; Kim N; Yoo YJ; Kim H; Jeong E; Choi S; Moon SU; Oh SH; Mills GB; Yoon S; Kim WY
Oncogene; 2018 Oct; 37(40):5466-5475. PubMed ID: 29895971
[TBL] [Abstract][Full Text] [Related]
32. 2-Methoxyestradiol-Mediated Induction of Frzb Contributes to Cell Death and Autophagy in MG63 Osteosarcoma Cells.
Bravo D; Shogren KL; Zuo D; Wagner ER; Sarkar G; Yaszemski MJ; Maran A
J Cell Biochem; 2017 Jun; 118(6):1497-1504. PubMed ID: 27883247
[TBL] [Abstract][Full Text] [Related]
33. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
[TBL] [Abstract][Full Text] [Related]
34. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity.
Hoogeboom D; Essers MA; Polderman PE; Voets E; Smits LM; Burgering BM
J Biol Chem; 2008 Apr; 283(14):9224-30. PubMed ID: 18250171
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract][Full Text] [Related]
36. γ-Tocotrienol inhibits cell viability through suppression of β-catenin/Tcf signaling in human colon carcinoma HT-29 cells.
Xu W; Du M; Zhao Y; Wang Q; Sun W; Chen B
J Nutr Biochem; 2012 Jul; 23(7):800-7. PubMed ID: 21852086
[TBL] [Abstract][Full Text] [Related]
37. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
38. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
[TBL] [Abstract][Full Text] [Related]
39. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
[TBL] [Abstract][Full Text] [Related]
40. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
